Abu Dhabi forges global health ties with US giants

Abu Dhabi is positioning itself as a global healthcare innovation hub, sealing major partnerships with Abbott, Sanofi, and Boehringer Ingelheim during a strategic mission to the US. These deals target critical areas for long-term healthcare resilience: digital health, vaccine development, and local pharmaceutical manufacturing.

Abbott’s agreement prioritises biosimilar development and the digitisation of health product data, aligned with the UAE’s digital health vision. Sanofi will tap into Abu Dhabi’s research infrastructure to bolster vaccine R&D and regional manufacturing capacity. Meanwhile, Boehringer Ingelheim is offering access to its OpnME platform to accelerate clinical research in the Emirate.

Abu Dhabi is not just participating in the future of healthcare, it’s actively shaping it. For private healthcare executives, the implications are wide-reaching, from supply chain diversification to new opportunities in AI-driven R&D and cross-border collaboration.

Read the full article to explore what this means for your strategic partnerships and innovation roadmap.